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Guidelines on asthma management have changed considerably in the last two decades. Patient education has gained 
in popularity and especially asthma self-management training is thought to be essential in the treatment of adult 
asthma. Since 1989 many researchers have added self-treatment guidelines to self-management programmes and 
several studies have found improvements in health outcomes, such as lung function, quality of life, use of health care 
facilities and asthma symptoms. However, because of the lack of proper control groups, it is not clear whether this 
has to be attributed to self-treatment guidelines or to, for example, more education or more medical attention. The 
only two studies that were placebo controlled did not show an effect of self-treatment. 
To assess the added benefit of self-treatment guidelines to a self-management programme, randomized ‘placebo’ 
controlled trials of sufficient size with sufficient follow-up time are necessary. The only difference between 
intervention and control groups should be guidelines for self-treatment. 
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Introduction 
Guidelines on asthma management have changed consider- 
ably in the last two decades. Patient education has gained in 
popularity and especially asthma self-management training 
is thought to be essential in the treatment of adult asthma 
(1,2). However, only a few publications are available as 
to what constitutes self-management. Two aspects in the 
management of a patients asthma will be discussed: self- 
management and self-treatment. In this paper ‘self- 
management’ will be defined as effective behaviour with 
regard to asthma, based on sufficient knowledge about 
asthma and its provoking factors, adequate coping 
behaviour, compliance with inhaled medication, attention 
to changes in the severity of the disease, adequate 
inhalation technique and the correct use of a peak flow 
meter. One of the components of self-management believed 
to be of importance is the self-adjustment of the inhaled 
medication by the patient with changing disease severity. 
We will use the term ‘self-treatment’ when patients are 
provided with guidelines to self-adjust their inhaled steroids 
or to start a short course of oral steroids when neces- 
sary, based on peak expiratory flow (PEF) values and/or 
symptom perception. 
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The first study that formally provided self-treatment 
guidelines as part of a self-management programme, was 
performed by Beasley et al. in 1989 (3). Their impressive 
results inspired many researchers and clinicians to add 
self-treatment guidelines to self-management programmes 
(4-18). However, its efficacy remains to be proven, because 
most studies were designed to evaluate a self-manage- 
ment programme as a whole, including education, more 
(medical) attention and guidelines for self-treatment. There- 
fore they were not able to demonstrate the efficacy of 
self-treatment guidelines. This paper is aimed at evaluating 
available knowledge on the efficacy of self-treatment 
guidelines. - 
The Rationale of Self-treatment 
Guidelines 
Intuitively, self-treatment is a very appealing concept. 
When patients are taught to self-intervene early in case of 
an asthma exacerbation, an acute deterioration in lung 
function could be curtailed at an early stage, which could 
result in reduced morbidity and mortality. Patients would 
probably feel more confident about their disease, and their 
quality of life and lung function could improve. Because the 
need for medical interventions would be less, costs could be 
reduced. This almost sounds too good to be true. On the 
other hand, the question arises whether the same results 
could be accomplished by educating patients thoroughly 
about their asthma, its provoking factors and their 
0 1998 W. B. SAUNDERS COMPANY LTD 
SELF-TREATMENT GUIDELINES FOR ASTHMATICS 669 
medication use: and by giving them more time and atten- 
tion and finally by optimizing their treatment, without 
issuing formal written self-treatment guidelines. 
What would then be the rationale for a written self- 
treatment plan? The theory behind self-treatment guidelines 
is that increasing knowledge of asthma is not sufficient to 
change behaviour of asthmatic patients and does not lead 
to improved health (19). One way to achieve behavioural 
changes is to increase the patients self-efficacy expectations, 
preferably by letting the patient experience successful 
behaviour (20). Self-treatment would fit very well in this 
approach. 
The Available Evidence for Efficacy of 
Self-treatment 
A literature search (Medline SilverPlatter) for the period 
1985 through November 1996 was performed to identify 
self-management trials that incorporated self-treatment 
guidelines in their programme. The following combination 
of keywords was used: (asthma and adult) and (self-care or 
self-administration or self-medication or patient education). 
This rendered 273 articles, of which only papers in English, 
dealing with structured education in adult asthmatics, were 
included. All abstracts were read to assess whether self- 
treatment was part of the education. This resulted in 31 
articles, which were thoroughly screened for the presence of 
self-treatment guidelines, after which 16 remained. Two 
papers described different aspects of the same study (7,15) 
so 15 independent studies were finally selected. The main 
characteristics for both controlled and uncontrolled studies 
are summarized (Tables 1 and 2). 
Beasley and colleagues (U.K., 1989) (3) evaluated 
instructions on how to use a self-treatment plan in an 
uncontrolled trial. They found an increase in lung function 
(FEV, and FVC) and reductions in days lost from school or 
work, nocturnal wakenings and use of oral steroids and 
antibiotics. Interpretation is difficult, because medical 
treatment was optimized (more inhaled steroids) and more 
attention was given. 
Worth (Germany, 1990) (9) performed a l-year, before- 
after, uncontrolled trial in 58 patients in which an extensive 
5-day inpatient educational programme was evaluated. 
Nocturnal attacks, exacerbations, sick-leave days and 
hospitalizations were approximately halved in the year 
following the intervention, compared with the year before. 
Mayo et al. (U.S.A., 1990) (4) evaluated a two-step 
self-treatment plan among severe asthma patients requiring 
multiple hospitalizations, in a randomized controlled trial 
(RCT). When patients experienced a severe attack, they had 
to take oral prednisone for 3 days and they had to increase 
their inhaled steroids for 1 week. They found an impressive 
reduction in hospital admissions and hospital days. 
Ringsberg and co-workers (Sweden, 1990) (6) evaluated 
an ‘asthma school’. Although they state that early drug 
treatment was part of the programme, it is unclear whether 
formal self-treatment with written guidelines was part of it. 
Quality of life increased in both groups, while the number 
of days in hospital decreased relatively more in the inter- 
vention group (83%) than in the control group (74%). It is 
striking that FEV, values increased significantly only in the 
control group. 
Charlton and colleagues (UK, 1990 and 1991) (7,15) 
randomly allocated asthma patients into a group receiving 
peak-flow-based self-management and a group receiving 
symptom-based self-management, all based on individual 
counselling. They observed a reduction in doctor consulta- 
tions, the need for oral steroids and days lost from work or 
school. 
Mtihlhauser et al. (Germany, 1991) (5) evaluated the 
same programme as Worth (9) in a large (~2 - i = 132) 
before-after, uncontrolled trial in which an extensive 5-day 
inpatient educational programme was evaluated during 
1 yr. The number of exacerbations, hospitalizations and 
days lost from work decreased. 
Charlton and co-workers (U.K., 1992) (14) also evalu- 
ated a nurse-run asthma clinic with 105 patients who were 
given self-treatment guidelines based on both peak flow and 
symptoms. Improvements were recorded for attacks of 
wheeze, nocturnal asthma attacks, overall trouble with 
asthma, interference of asthma in the patients life, walking 
uphill, climbing stairs, general practitioner home visits and 
the number of days lost from work or school, 
Yoon et al. (Australia, 1993) (8) performed an RCT with 
76 patients and found a reduction in re-admission rate and 
emergency room visits in the intervention group compared 
with the control group. 
The GRASSIC study (U.K., 1994) (18) evaluated a 
three-step self-treatment plan among asthma patients who 
were not already using a PEF meter. When PEF fell below 
a certain level (individually tailored, but without further 
details), patients had to take oral prednisone. If PEF fell 
further, below another (unspecified) level, patients should 
seek immediate medical assistance. This was a randomized 
placebo-controlled trial among 569 patients. Patients were 
not formally educated, although a subgroup of 137 patients 
in the intervention group and 143 from the control group 
received educational booklets. The intervention group 
received a PEF meter and guidelines on how to use it. Oral 
steroids were prescribed more often to patients with severe 
asthma in the intervention group, and patients with a PEF 
meter who also received ‘integrated’ care reported less 
restricted activity. No effect of the booklets was reported 
and no other differences between the two groups were 
found. 
D’Souza and co-workers (New Zealand, 1994) (10) intro- 
duced a ‘credit-card’ self-management plan in a Maori 
community. Despite the short follow-up period (16 weeks), 
results were impressive: a 12% increase in peak flow was 
observed, the percentage of nights woken and days out 
of action was approximately halved, and a three-fold 
reduction in emergency department visits and hospital 
admissions was found. 
Boulet and colleagues (Canada, 1995) (13) did a ‘case- 
controlled retrospective study’ in which patients were 
matched for age, sex and medication needs. In comparison 
with the control group, the intervention group showed a 
reduction in the number of days off work and emergency 
room visits. 
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TABLE 2. Overview of contents of the self-treatment guidelines 
Study 
Type of 
guidelines* PEF zones? Action 
Yoon et al. (8) (1993)s 
GRASSIC (18) (1994) 
D’Souza et a1.(10) (1994) 
Beasley et al. (3) (1989) PEF 
Worth (9)$ (1990) PEF and symptoms 
Mayo et al. (4) (1990) PEF and symptoms 
Ringsberg et al. (6) (1990) ? 
Charlton et al. (7,15) (1990 and 1991) PEF or symptoms 
Miihlhauser et al. (5) (1991) 
Charlton et al. (14) (1992) 
PEF and symptoms 
PEF and symptoms 
PEF and symptoms 
PEF 
PEF and symptoms 
Boulet ei al. (13) (1995) 
Ignacio-Garcia et al. (11) (1995) 
Jones et al. (12) (1995) 
PEF 
PEF 
PEF 
D’Souza et aL(17) (1996) PEF and symptoms 
Lahdensuo et al. (16) (1996) PEP 
100-70 
70-50 
<50 
< 150-200 
Not mentioned 
Not mentioned 
? 
100-70 
70-50 
50-30 
<30 
Not mentioned 
100-70 
70-50 
50-30 
<30 
100-80 
80-70 
70-60 
~60 
Not mentioned 
(three unspecified 
levels) 
100-80 
80-60 
60-40 
<40 
? 
100-70 
70-50 
<50 
100-75 
75-50 
50-25 
<25 
100-80 
80-60 
60-40 
<40 
100-85 
85-70 
<70 
Continue regular medication 
Double inhaled steroids 
Start oral steroids 
Seek help 
? 
? 
7 
Continue regular medication 
Double inhaled steroids 
Start oral steroids 
Seek help 
7 
Continue regular medication 
Double inhaled steroids 
Start oral steroids 
Seek help 
Continue regular medication 
Double inhaled steroids 
Start oral steroids 
Seek help 
Continue regular medication 
Start oral steroids 
Seek help 
Continue regular medication 
Double inhaled steroids 
Start oral steroids and call doctor 
Seek help 
? 
Continue regular medication 
double inhaled steroids 
Start oral steroids and seek help 
Continue regular medication 
Double inhaled steroids 
Start oral steroids and call doctor 
Seek medical help 
Continue regular medication 
Double inhaled steroids 
Start oral steroids and call doctor 
Seek help 
Continue regular medication 
Double inhaled steroids 
Start oral steroids and seek help 
*Guidelines based on PEF, symptoms, or both. 
tpercentage of personal best PEF or percentage predicted. 
$Based on description from the same asthma education programme by Mtihlhauser et al. (5). 
§Based on reference to manuscript by Woolcock et al. (21). 
Ignacio-Garcia et al. (Spain, 1995) (11) were able to show 
remarkable improvements in lung function and reductions 
in the number of exacerbations, days lost from work, 
physician consultations, emergency room admissions and 
number of hospital admissions, with a relatively small 
number of patients receiving individual counselling, com- 
pared with a control group that did not receive any 
education. 
Jones and colleagues (UK; 1995) (12) have performed the 
only other randomized placebo-controlled trial among 72 
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patients to assess the efficacy of self-treatment based on 
home peak flow monitoring. There were no differences 
between the two groups in lung function, symptoms, quality 
of life and costs for treatment. Only the self-treatment 
group showed improvements in quality of life and distur- 
bance of daily activities. 
In another study, D’Souza et ul. (New Zealand, 1996) 
(17) offered a ‘credit-card’ self-management plan to a group 
of 30 asthma patients discharged from the emergency 
department. The number of emergency department visits 
decreased significantly as well as asthma morbidity. Unfor- 
tunately, severe selection occurred in the recruitment of 
patients. 
Lahdensuo and coworkers (Finland, 1996) (16) com- 
pared the efficacy of self-management of asthma with 
traditional treatment in 11.5 patients with mild to moder- 
ately severe asthma. The number of unscheduled visits to 
ambulatory care facilities, days off work and courses of 
antibiotics and prednisolone per patient were lower and the 
quality of life score was higher in the self-management 
group than in the traditionally treated group following the 
educational programme. No changes in lung function were 
observed. 
In summary, the available evidence for the efficacy of 
guidelines for self-treatment is far from complete. Several 
studies show improvements in health outcomes, such as 
lung function, quality of life, use of health care facilities and 
asthma symptoms, but because of the lack of proper 
control groups, it is not clear whether this can be attributed 
to self-treatment or to other aspects of asthma self- 
management, such as more medical attention and educa- 
tion. The only two placebo-controlled studies showed only 
little or no effect of self-treatment guidelines. It has to be 
said, however, that those two studies did not provide 
patients with additional education or training. 
The Paradigm of the Randomized 
Controlled Trial 
Most studies mentioned above did not follow the principles 
of the RCT and its requirements, which is imperative for 
studies on drug efficacy. It should be noted that self- 
management research is relatively new to medicine, and 
clear guidelines on how to perform these studies, evaluating 
behavioural changes, were not available. The early studies 
evaluated the overall impact of self-management on mor- 
bidity or quality of life. Now it is time to identify the key 
elements (e.g. self-treatment) of a self-management pro- 
gramme. Given the present state of knowledge regarding 
self-management and self-treatment, there is no compelling 
reason why a self-management trial should not be executed 
as a placebo-controlled RCT, as the concept of testing the 
efficacy of self-treatment in asthma self-management train- 
ing is identical to testing a new medical drug. A proper 
RCT on asthma self-management, trying to establish the 
added value of self-treatment guidelines, has to conform 
with at least three criteria: (1) relevance, (2) validity and (3) 
sufficient power and maximum efficiency (21). 
RELEVANCE 
(a) The trial should show relevance with regard to 
the intervention itself. The intervention to be tested 
should have the most potential to improve outcomes. 
In this respect, adding self-treatment guidelines to self- 
management education is intuitively logical. 
(b) The trial should show relevance with regard to the 
intended health objectives. For self-management education, 
behavioural change is the minimum intended effect and 
should therefore be assessed. 
(c) The trial should show relevance with regard to the 
intended patient population, so the study population has to 
reflect the population of asthmatics one is aiming to reach 
with the self-management programme. 
VALIDITY 
A trial should provide a valid i.e. unbiased, test of the 
efficacy of self-treatment guidelines. This means com- 
parability of the following. 
(a) Populations. Intervention- and control groups 
should have comparable distributions of patient character- 
istics and extraneous determinants that are predictive for 
the outcome of interest. This can be achieved by stratified 
randomization. 
(b) Effects. Intervention and control strategies should 
give similar outcome results in case self-treatment guide- 
lines are ineffective. To this end placebo treatment is 
necessary. For studies on the added value of self-treatment 
guidelines to self-management education, this can be 
achieved by giving an equal amount of (medical) attention 
and education to patients in the intervention group and 
the control group. The only difference between the 
groups should be the guidelines for self-treatment. 
(c) Information. Double blinding (patients and observ- 
ers) is introduced to prevent incomparability of infor- 
mation. As blinding is not easily achieved in asthma 
self-management research, objectivity and standardization 
of outcome measurements are crucial. 
SUFFICIENT POWER AND MAXIMUM 
EFFICIENCY 
(a) The number of patients has to be sufficient. This 
means that studies should have enough power to detect a 
relevant difference between groups of specified size. 
(b) Homogeneous patient groups should be selected. 
Conditional on the number of patients, the power and 
efficiency of the study can be increased by selecting 
homogeneous patient groups. 
(c) Patients should have a potential for improvement. 
However, the patients’ asthma should be stable at the start 
of the study, for two reasons. First, self-treatment guide- 
lines are based on a personal best PEF, but unstable 
patients will not reach their true maximal PEF. Secondly, 
if the patients asthma is not stable, improvements will 
probably occur because of more effective treatment. 
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Discussion of the Studies 
Several points, important to the relevance of the outcomes, 
arise when evaluating the above-mentioned studies. Table 1 
summarizes all 15 studies and the quality criteria mentioned 
above with regard to relevance, validity and sufficient 
power and maximum efficiency. 
RELEVANCE 
None of the interventions was explicitly based on 
behavioural principles and only six trials evaluated 
changes in behaviour following the programme using either 
questionnaires or peak flow diaries and/or medication 
reports. Yoon et al (8) used a questionnaire to obtain 
information on changes in self-management behaviour and 
found that the intervention group showed a greater propor- 
tional improvement (+66%) compared with the control 
group (- 9%) on questions related to self-management 
skills. The GRASSIC study (18) evaluated self-efficacy in 
both groups but does not report on changes over time. 
Boulet and co-workers (13) included questions pertaining to 
‘what to do during exacerbations’ in a knowledge question- 
naire and they found a 21% increase in knowledge in the 
intervention group; 1 yr after the programme. Unfortu- 
nately it is not clear what the increase for the specific 
questions on behaviour during exacerbations was. Jones 
and colleagues (12) evaluated self-treatment behaviour 
during exacerbations of asthma using peak flow diaries. Of 
the 20 subjects (51%) who experienced an exacerbation nine 
(45%) were fully compliant with doubling inhaled steroids 
and a further three complied during at least half of their 
episodes (67% ‘compliers’ in total); eight (40%) never 
complied. It must be noted that compliance was based on 
self-report. In a study by D’Souza et aZ. (17) 20 of the 26 
study participants (77%) stated that they had used the 
self-treatment instructions on the credit card to increase the 
amount of inhaled steroids. Of the ten patients who 
required a course of prednisone, six had self-initiated the 
treatment and four had initiated treatment with the assist- 
ance of a doctor. Both sides of the card (peak flow and 
symptoms) were found to be equally helpful by 50%, 
and 42% thought the peak flow side was more helpful. 
Lahdensuo and co-workers (16) used peak flow diary cards 
and noted that 32 patients (57%) had peak Aow values 
falling more than 15% at least once during the study year, 
yielding a total of 141 episodes. Three patients (9%) did not 
double their inhaled steroids in any episode, 11 (34%) 
doubled the dose occasionally and 18 patients (56%) always 
doubled the dose. Peak flow values decreased more than 
30% on 13 occasions and a course of oral prednisolone was 
started in ten instances. 
Eight studies had a 1 yr follow-up period, while this 
varied from 4 to 10 months in the others. In general, a 
follow-up period should be long enough for desired changes 
to take place. On the other hand, patients might change 
their behaviour, immediately following the intervention, 
but the initial effect might wear off after a few months. 
Intuitively, and not supported by hard evidence, one would 
choose a period of 1 yr or preferably 2 yr of follow-up. One 
of the reasons is the influence of seasonal variation on lung 
function. 
Selective sampling or participation occurred in at least 
seven studies, In two studies (7; 14,15) the study population 
was recruited by invitational letters to eligible patients, 
leading to low response rates. Similarly, Jones (12) invited 
90 GP practices to participate in their study, but only 25 
successfully recruited patients. D’Souza (10) recruited 
Maori patients through ‘established community networks, 
not resulting in a random selection of asthmatic indi- 
viduals’, and in another study only 13% of approached 
patients were included in the study (17). Yoon (8) person- 
ally identified 185 eligible and willing patients during 
their stay in hospital, of whom only 76 attended the 
single educational session. Attenders were predominantly 
female non-smokers with more than 10 yr of schooling. In 
the GRASSIC study a number of more severe patients were 
already prescribed a PEF meter before the start of the study 
and were therefore not eligible for randomization. 
Finally, only six trials explicitly selected patients on 
inhaled or oral steroids prior to the study. This is an 
important factor, because it is very likely that patients who 
are not on inhaled or oral steroids prior to enrohnent in the 
study will benefit from these medicines when they are added 
to their treatment regimen. Also, an increase in the dosage 
of inhaled or oral steroids would probably be beneficial to 
patients who are on a lower dose at the start of the study. In 
such instances, it would be incorrect to ascribe improved 
outcomes solely to the guidelines for self-treatment. In the 
study by Beasley et al. (3) eight patients (27%) previously 
not taking inhaled steroids, were on a maintenance dose of 
beclomethasone of 350 ug (200-1000 ug) at the final visit. In 
the 22 patients (73%) who were already on an average dose 
of 805 ug (200-2000 ug) at the initial visit, this increased to 
1130 ug (ZOO-2000 ug). Worth (9) trained patients who 
were admitted to hospital; during this 5-day course drug 
therapy was optimized. Information on medication use 
prior to admission is lacking. Mayo and colleagues (4) 
enrolled 56 patients in a self-management programme. 
Before enrolment, 20% were on chronic inhaled cortico- 
steroids and 25% were on chronic daily prednisone. After 
enrollment this changed to 82% and 9% respectively. 
Ringsberg et al. included 38 patients in a 1 yr RCT, but 12 
patients (32%) were not using steroids (6). No other infor- 
mation on medication use is presented, so it is not clear 
whether this had changed or not. Miihlhauser and co- 
workers (5) give a detailed description of the changes in 
medication in their patients. On admission 59 patients used 
on average 750 ug (400-1000 ng) of beclomethasone. At 
discharge this had increased to 65 patients using on average 
920 pg (750-1000 ug). After 1 yr 70 patients were using on 
average 930 ug (750-1000 ug). For oral prednisolone the 
corresponding numbers were 57 patients using 14 mg 
day- ’ (8-20 mg day- ‘), 65 patients using 27 mg day-’ 
(15-40 mg day - ‘) and 43 patients using 15 mg day - ’ 
(8-20 mg day- ‘). It is not clear from the data whether 
some patients were using both types of steroids or none. 
Yoon et al. (8) observed an increase in the use of inhaled 
steroids, from 43% of all patients, before admission, to 50% 
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in the intervention group and 61% in the control group 
after 10 months. The GRASSIC study did not state the 
number of patients on inhaled steroids, but as the dose of 
inhaled steroids did not change over the year, this will not 
have influenced results. In one study by D’Souza et al. (IO) 
the percentage of patients reporting that they were pre- 
scribed inhaled steroids increased from 61% to 93%. The 
authors state ‘Of perhaps greater health significance, is the 
increase from 39% to 91% of participants who indicated 
that inhaled steroids were prescribed for regular use.’ In 
another study (17), the same research group found an 
increase in the use of inhaled steroids from 73% to 100% 
among the 26 patients who completed the study. The mean 
prescribed dose of inhaled steroids increased approximately 
two-fold. 
VALIDITY 
Seven trials used a pre-test post-test design. One trial (13) 
assigned patients to an intervention group and later 
matched these with a control group, while in six studies 
patients were randomized into an intervention or control 
group. When no control group is used, it is not possible to 
separate effects of the various components of the self- 
management programmme. Therefore, a pre-test post-test 
design is not suitable to test the efficacy of adding self- 
treatment to a self-management education programme. 
This is also true for controlled studies, when there are more 
differences between the intervention and control group than 
just the guidelines for self-treatment of exacerbations of 
asthma. If the control group is a ‘regular care’ control 
group, there will almost always be other differences in 
favour of the intervention group, such as more education 
and more time spent on them, more medical attention and 
often also alterations in the prescribed medication. Most of 
the controlled studies are not appropriately controlled with 
regard to self-treatment guidelines. For example, patients in 
the intervention group in Ignacio-Garcia et als study (11) 
improved quite a lot compared with regular controls, 
but this does not necessarily mean that this is caused by 
the self-treatment guidelines. The favourable outcome 
measures could also be explained by patient education or 
more effective pharmacotherapeutic treatment. Probably 
many aspects, including self-treatment, contributed to the 
observed improvements, but to what extent cannot be 
determined. Therefore, with respect to the effect of the 
entire intervention as a whole, the study is adequately 
controlled, but, with regard to the single component of 
self-treatment guidelines, the study has to be considered 
inappropriately controlled. To overcome this problem, it is 
necessary to use a placebo-control group that will receive 
the same amount of education, time spent on them and 
medical attention and will also receive the same alterations 
in the prescribed medication as the intervention group. 
Only Jones and colleagues and the GRASSIC study 
designed a ‘placebo’ controlled study (12) and they were 
unable to demonstrate between-groups differences in lung 
function, symptoms, quality of life and costs for treatment. 
These two studies found no proof for the efficacy of 
self-treatment guidelines, but it must be noted that no 
formal education and/or training was provided; thus one 
cannot speak of the ‘added value’ of self-treatment to a 
self-management programme. 
None of the studies used a single- or double-blind design, 
which is indeed difficult to achieve, especially if the 
physician is one of the researchers. 
SUFFICIENT POWER AND MAXIMUM 
EFFICIENCY 
Every published trial reported a treatment effect in at least 
one parameter. It is likely that negative studies, because of 
insufficient power, are selectively not reported (publication 
bias). 
Explicit inclusion and exclusion criteria are seldom pre- 
sented; this makes it difficult to judge the homogeneity of 
the study samples. Most studies selected patients whose 
lung function parameters could improve substantially, 
except in the study by Jones et al. (12), whose patients were 
all given oral steroids at the start of the study to optimize 
lung function. 
In only seven studies could it be assumed that patients 
were stable at the start of the study. If patients are not well 
controlled at the first visit, it is very likely, that improve- 
ments in outcomes are, in part, caused by adequate medical 
treatment, following enrolment in the study. 
In summary: of all studies described above, only two 
were placebo controlled and these studies failed to show 
evidence of the efficacy of self-treatment. The design of the 
other studies does not permit conclusions about the efficacy 
of self-treatment. 
Suggestions for Future Research 
It still is not clear whether guidelines for self-treatment are 
effective in reducing morbidity. To assess the added benefit 
of self-treatment guidelines to a self-management pro- 
gramme, randomized, ‘placebo’ controlled trials of suffi- 
cient size with sufficient follow-up time are necessary. These 
studies should be done in patients in general practice, 
hospital outpatients and hospitalized patients. The only 
difference between intervention and control groups should 
be guidelines for self-treatment. At least one self- 
management trial incorporating self-treatment guidelines, 
in an adult outpatients asthma population, is underway in 
The Netherlands, following the paradigm of the RCT. So 
far, study results seem promising as to the role of self- 
management and self-treatment in the improvement of 
asthma care. Results of additional studies with proper 
design, addressing the efficacy of self-treatment guidelines, 
should be available before these time-consuming and 
expensive programmes are offered to adult asthmatics. 
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